Extracorporeal Support Considerations in Older Patients

Abstract

With the aging of global populations, the use of extracorporeal support modalities, such as extracorporeal membrane oxygenation (ECMO) and ventricular assist devices (VADs), in older patients is increasing. This review examines the epidemiology, pathophysiology, risk factors, clinical features, diagnostic considerations, management strategies, and recent advances in extracorporeal support for older adults. We provide a synthesis of current guideline recommendations, highlight clinically relevant evidence, and discuss the unique challenges and practical implications associated with this vulnerable population.

Introduction

Extracorporeal support has revolutionized the management of severe cardiac and respiratory failure. However, the application of these life-sustaining technologies in older patients presents distinct clinical, ethical, and logistical challenges. Age-associated comorbidities, frailty, and altered physiological reserves necessitate careful patient selection and tailored management strategies. As the proportion of older adults in critical care rises, understanding the nuanced considerations for extracorporeal support in this group is essential for optimizing outcomes.

Epidemiology / Disease Burden

The incidence of acute cardiac and respiratory failure requiring extracorporeal support increases with age, reflecting the higher prevalence of chronic organ dysfunction in older adults. Registry analyses demonstrate that patients over 65 years now account for a significant and growing proportion of ECMO and VAD recipients. Despite this trend, older age remains associated with increased mortality and morbidity following extracorporeal support. The disease burden is compounded by the higher baseline prevalence of multi-organ dysfunction, polypharmacy, and pre-existing functional limitations found in elderly populations.

Pathophysiology

The pathophysiological response to critical illness and extracorporeal support in older patients is shaped by age-related changes in cardiovascular, pulmonary, and immune function. Reduced cardiac contractility, impaired vascular compliance, diminished pulmonary reserve, and altered immune responses can influence both the need for and the response to extracorporeal therapies. Additionally, older adults are more susceptible to systemic inflammatory responses and coagulopathies triggered by extracorporeal circuits, increasing the risk of complications such as bleeding, thrombosis, and infection.

Risk Factors

Key risk factors impacting outcomes in older patients on extracorporeal support include advanced age (>70 years), frailty, comorbidities such as chronic kidney disease, diabetes, and chronic obstructive pulmonary disease, as well as pre-existing cognitive impairment and poor functional status. The presence of multi-morbidity and cumulative organ dysfunction at the time of support initiation are strongly predictive of adverse outcomes. Recent studies emphasize the importance of pre-procedural frailty assessments and multidisciplinary evaluations to inform prognostication and decision-making.

Clinical Features

Older patients requiring extracorporeal support frequently present with more insidious clinical deterioration, atypical symptoms, and overlapping chronic conditions. Delirium, functional decline, and subtle cognitive changes may be early indicators of decompensation. The manifestation of sepsis, hypoxemia, or cardiogenic shock can be less dramatic, necessitating a high index of suspicion and comprehensive geriatric assessment to identify those most likely to benefit from advanced support modalities.

Diagnosis

Diagnostic evaluation in older adults should integrate standard hemodynamic and respiratory assessments with geriatric-specific considerations such as cognitive status, frailty scoring, and functional baseline. Laboratory and imaging modalities remain essential for defining the extent and reversibility of organ dysfunction. Emerging biomarkers, including lactate and procalcitonin, can aid in risk stratification, though their interpretation may be confounded by age-related physiological changes. Early involvement of multidisciplinary teams, including geriatrics, is recommended to ensure holistic assessment.

Treatment & Management

Management of older patients on extracorporeal support requires individualized, goal-directed care. Anticoagulation protocols may need adjustment due to altered pharmacodynamics and increased bleeding risk. Nutritional support, delirium prevention, and early mobilization are integral components of care. Decisions regarding initiation, continuation, or withdrawal of support should be guided by established goals of care, patient preferences, and realistic prognostic discussions. Palliative care integration is essential to address symptom burden and facilitate shared decision-making.

Recent Advances / Emerging Therapies

Technological innovations, including miniaturized ECMO circuits, improved biocompatible materials, and automated anticoagulation monitoring, have enhanced the safety profile of extracorporeal support in older adults. Recent studies suggest that frailty-based risk stratification tools and geriatric co-management models can improve patient selection and outcomes. The use of temporary mechanical circulatory support as a bridge to recovery or decision is being explored in select elderly cohorts, though robust evidence from randomized controlled trials is still emerging.

Guideline Recommendations

Current international guidelines advocate for individualized candidacy assessment for extracorporeal support in older patients, emphasizing the need for multidisciplinary evaluation and consideration of frailty, comorbidities, and patient-centered outcomes. The Extracorporeal Life Support Organization (ELSO) recommends that age alone should not be an absolute contraindication but highlights the importance of weighing risks and benefits in the context of global health status and goals of care. Early palliative care consultation is increasingly endorsed as best practice in this setting.

Conclusion

The use of extracorporeal support in older patients is a rapidly evolving field characterized by complex clinical, ethical, and logistical considerations. While age-associated risks are significant, careful patient selection, comprehensive geriatric assessment, and individualized management strategies can optimize outcomes. Ongoing research and guideline refinement are essential to further define best practices and improve survival and quality of life for older adults requiring extracorporeal support.